U.S. flag

An official website of the United States government

NM_001613.4(ACTA2):c.146T>C (p.Met49Thr) AND Aortic aneurysm, familial thoracic 6

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 29, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002531810.9

Allele description [Variation Report for NM_001613.4(ACTA2):c.146T>C (p.Met49Thr)]

NM_001613.4(ACTA2):c.146T>C (p.Met49Thr)

Gene:
ACTA2:actin alpha 2, smooth muscle [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.31
Genomic location:
Preferred name:
NM_001613.4(ACTA2):c.146T>C (p.Met49Thr)
HGVS:
  • NC_000010.11:g.88947370A>G
  • NG_011541.1:g.49021T>C
  • NM_001141945.3:c.146T>C
  • NM_001320855.2:c.146T>C
  • NM_001406462.1:c.146T>C
  • NM_001406463.1:c.146T>C
  • NM_001406464.1:c.146T>C
  • NM_001406466.1:c.146T>C
  • NM_001406471.1:c.146T>C
  • NM_001613.4:c.146T>CMANE SELECT
  • NP_001135417.1:p.Met49Thr
  • NP_001135417.1:p.Met49Thr
  • NP_001135417.1:p.Met49Thr
  • NP_001307784.1:p.Met49Thr
  • NP_001307784.1:p.Met49Thr
  • NP_001393391.1:p.Met49Thr
  • NP_001393392.1:p.Met49Thr
  • NP_001393393.1:p.Met49Thr
  • NP_001393395.1:p.Met49Thr
  • NP_001393400.1:p.Met49Thr
  • NP_001604.1:p.Met49Thr
  • NP_001604.1:p.Met49Thr
  • LRG_781t1:c.146T>C
  • LRG_781t2:c.146T>C
  • LRG_781:g.49021T>C
  • LRG_781p1:p.Met49Thr
  • LRG_781p2:p.Met49Thr
  • NC_000010.10:g.90707127A>G
  • NM_001141945.1:c.146T>C
  • NM_001141945.2:c.146T>C
  • NM_001320855.1:c.146T>C
  • NM_001613.2:c.146T>C
Protein change:
M49T
Links:
dbSNP: rs869025352
NCBI 1000 Genomes Browser:
rs869025352
Molecular consequence:
  • NM_001141945.3:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320855.2:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406462.1:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406463.1:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406464.1:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406466.1:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406471.1:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001613.4:c.146T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Aortic aneurysm, familial thoracic 6 (AAT6)
Synonyms:
FAMILIAL THORACIC AORTIC ANEURYSM WITH LIVEDO RETICULARIS AND IRIS FLOCCULI
Identifiers:
MONDO: MONDO:0012730; MedGen: C2673186; OMIM: 611788

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003309767Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 29, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections.

Hoffjan S, Waldmüller S, Blankenfeldt W, Kötting J, Gehle P, Binner P, Epplen JT, Scheffold T.

Eur J Hum Genet. 2011 May;19(5):520-4. doi: 10.1038/ejhg.2010.239. Epub 2011 Jan 19.

PubMed [citation]
PMID:
21248741
PMCID:
PMC3083620

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV003309767.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

ClinVar contains an entry for this variant (Variation ID: 519576). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 49 of the ACTA2 protein (p.Met49Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of ACTA2-related conditions (Invitae). It has also been observed to segregate with disease in related individuals. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACTA2 protein function. This variant disrupts the p.Met49 amino acid residue in ACTA2. Other variant(s) that disrupt this residue have been observed in individuals with ACTA2-related conditions (PMID: 21248741), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024